Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Maria Rosa
Maria Rosa Calautti, Oro Station CA
| Patent application number | Description | Published |
|---|---|---|
| 20100242156 | Self-supporting figure control pants - The invention provides a shape controlling outer pant garment with a pant portion and a self-fupporting upper shaped portion which surrounds and compresses the wearer while supported on the pant portion. | 09-30-2010 |
Maria Rosa Cuberes Altisen, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20090149472 | SALTS OF SUBSTITUTTED PYRAZOLINE COMPOUNDS, THEIR PREPARATION AND USE AND MEDICAMENTS - The present invention relates to salts of substituted pyrazoline compounds, methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans and animals. | 06-11-2009 |
Maria Rosa Cuberes Altisent, San Cugat Del Valles ES
| Patent application number | Description | Published |
|---|---|---|
| 20100105680 | SUBSTITUTED DIMETHYLCYCLOBUTYL COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS - The present invention relates to substituted dimethylcyclobutyl compounds of general formula I, a process for their preparation, medicaments comprising said substituted dimethylcyclobutyl compounds as well as the use of said substituted dimethylcyclobutyl compounds for the preparation of medicaments, which are particularly suitable for the prophylaxis and/or treatment of disorders or diseases that are at least partially mediated via sigma receptors. | 04-29-2010 |
Maria Rosa Faner Canet, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20090035776 | Method and Kit for Hla-B Genotyping Based on Real-Time Pcr - Method and kit based on real-time PCR with specific primers and probes that allow to achieve a high degree of subtyping of the complete HLA-B locus. The main advantages are the greater speed (65 minutes, including the interpretation); the ease of automation, since only eighteen tubes are necessary to obtain a good level of resolution (typing of 300 groups); reduction of the total cost per test thanks to the ease of automation and the simplicity; a surprisingly high degree of allele definition is achieved; and the risk of sample contamination is reduced because the amplified products always remain in the tubes and no post-PCR steps are necessary. | 02-05-2009 |
Maria Rosa Gasco, Torino IT
| Patent application number | Description | Published |
|---|---|---|
| 20080206341 | Lipid Nanoparticles as Vehicles for Nucleic Acids, Process for Their Preparation and Use - The invention relates to solid lipid nanoparticles composed of lipid material and containing, as bioactive molecule, a nucleic acid, preferably an antisense oligonucleotide, preferably modified by chemical methods to achieve a greater resistance to endo- and exo-nucleases, and to the process for preparation of the nanoparticles. In the present invention, the efficiency of the delivery system represented by nanoparticles containing synthetic or natural polynucleotides allows the use of such system for transfection. The particles are especially effective in the treatment of diseases of the posterior segment of the eye (such as diabetic retinopathy, macular degeneration, etc.) and in angiogenesis. | 08-28-2008 |
| 20090306032 | Use of solid lipid nanoparticles Comprising Cholesteryl Propionate and/or Cholesteryl Butyrate - The present invention refers to the use of solid lipid nanoparticles (SLN) obtained from warm microemulsions, containing cholesteryl propionate and/or cholesteryl butyrate, for preparation of a medicament for the prevention and treatment of vascular or inflammatory pathologies. | 12-10-2009 |
| 20100028432 | FORMULATIONS OF ACTIVE PRINCIPLES INCORPORATED IN SLNS SUITABLE FOR TRANSDERMAL ADMINISTRATION - The present invention relates to formulations suitable for transdermal administration characterized by containing SLNs which contain active principles with a very short half-life and/or drugs with high activity. | 02-04-2010 |
Maria Rosa Infante Martinez-Pardo, Jorge Girona Salgado Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20090203781 | N-N-Acyloxypropyl Lysine Methyl Ester-and N,N-Bis(N-Acyloxypropyl) Lysine Methyl Ester-Type Compounds and Use Thereof as Surface-Active Agents with an Antimicrobial Activity - The invention relates to novel compounds having an amphiphilic character (cationic, anionic, amphoteric and non-ionic), derivatives of n acyloxypropyl-type lysine amino acid according to general formula (I), which are intended to be used in the food, pharmaceutical and cosmetic industries as surface-active agents having a self-aggregating capacity and antimicrobial properties. Variations in activity are a function of the ionic nature of the final molecule, the number of fatty chains and the length thereof. The aforementioned products are prepared using a chemical synthesis method. The intermediate and final products are purified by means of liquid/liquid and liquid/solid extractions, crystallisations, cationic exchange chromatography and normal phase chromatography. | 08-13-2009 |
Maria Rosa Sarrias Fornés, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20100105622 | Protein Product for Treatment of Infectious Diseases and Related Inflammatory Processes - The inventors have found that CD6, a member of the Scavenger Receptor Cysteine-Rich (SRSR) superfamily expressed on human lymphocytes binds to Gram-positive and Gram-negative bacteria, as well as to other microbial structures. Thus, a CD6 product is useful for the manufacture of a medicament for therapeutic and/or preventive treatment of an infectious disease or of an inflammatory condition related to an infectious disease or to the presence of a product derived from an infectious agent in a mammal including a human. Examples of such inflammatory conditions are systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis and septic shock. | 04-29-2010 |
Maria Rosa Sarrias Fornés, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20100105622 | Protein Product for Treatment of Infectious Diseases and Related Inflammatory Processes - The inventors have found that CD6, a member of the Scavenger Receptor Cysteine-Rich (SRSR) superfamily expressed on human lymphocytes binds to Gram-positive and Gram-negative bacteria, as well as to other microbial structures. Thus, a CD6 product is useful for the manufacture of a medicament for therapeutic and/or preventive treatment of an infectious disease or of an inflammatory condition related to an infectious disease or to the presence of a product derived from an infectious agent in a mammal including a human. Examples of such inflammatory conditions are systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis and septic shock. | 04-29-2010 |